Toll‐like receptor 9 inhibition confers protection from liver ischemia–reperfusion injury
Zubin M. Bamboat, Vinod P. Balachandran, Lee M. Ocuin, Hebroon Obaid, George Plitas, Ronald P. DeMatteo – 25 January 2010 – Endogenous ligands such as high‐mobility group box 1 (HMGB1) and nucleic acids are released by dying cells and bind Toll‐like receptors (TLRs). Because TLR9 sits at the interface of microbial and sterile inflammation by detecting both bacterial and endogenous DNA, we investigated its role in a model of segmental liver ischemia–reperfusion (I/R) injury.